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Differences among Men and Women with Schizophrenia:
A Study of US and Indian Samples
ObjectiveaaTo test the hypothesis that similar differences in psychopathology are present 
across cultures among men and women with schizophrenia (SZ). 
MethodsaaSex based differences were tested systematically in two independent samples from 
the Northeastern USA and North India using the same procedures. The clinical variables 
were obtained from five interview instruments.
ResultsaaAmong the US participants, the number of significant differences exceeded chance 
predictions (15/240 variables significant at p<0.02, 6.25%; expected number of significant 
differences: 5). Similarly, a greater than expected number of variables differed significantly 
between men and women among the Indian subjects (13/230 differences at p<0.02, 5.65%; 
expected: 5). One of these variables significantly differed in both samples (lifetime abuse of 
cannabis). When multivariate analyses were conducted in the combined US and Indian sam-
ples sex based differences remained for only four variables: course of the illness, history of 
inappropriate emotions, marital status and number of children.
ConclusionaaSex based differences in SZ/schizoaffective disorder are present in the USA 
and India at greater than chance probabilities. The majority of the variables differ across the 
samples. The biological underpinnings of these variables need further investigation.
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Introduction
There has been extensive interest in sex differences in schizophrenia (SZ). The research 
runs the gamut from large scale epidemiological studies to smaller studies describing diagnos-
tic and clinical differences. Some studies, including meta-analyses, suggest a modest increase 
in the incidence and prevalence of SZ among men.
1-3 More substantive differences in clini-
cal features, particularly severity have been documented repeatedly. Women with SZ report 
affective symptoms, auditory hallucinations and persecutory delusions more frequently, 
with lower prevalence of smoking and substance abuse.
4 These authors also reported that 
male patients had more negative symptoms and cognitive deficits. Though a prospective, dou-
ble blind placebo controlled trial comparing 24 male and 20 female patients did not find sig-
nificant sex-based differences,
5 an extensive review suggested that optimal antipsychotic 
maintenance regimens differ between women and men.
6 A review of 76 studies on tardive 
dyskinesia (TD), published through 1989 suggested a significantly higher prevalence in wom-
en (26.6%) than in men (21.6%), with a tendency for more severe TD among women.
7
There is substantial evidence that men with SZ suffer a more severe form of the illness 
and a more malignant course than women.
8 Women also have significantly better social func-
tion.
4,9-11 Men are more likely to have an earlier age at onset, a variable correlated with more 
severe illness.
12-14 Sex significantly influenced global measures of function in a two year fol-
low-up of 200 patients.
15 A systematic meta-analysis of twenty three studies detected a high-
online © ML Comm10  Psychiatry Investig 2010;7:9-16
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ly significant association between male sex and deficit SZ 
[pooled odds ratio (OR)= 1.75].
16 Women with SZ exhibited 
a less deteriorated course of illness.
17 Not all studies have 
consistently reported a more severe form of illness among 
men.
11 Ten year follow up of 141 first admitted patients and 
patients with schizophreniform disorder reported no signifi-
cant difference between men and women in clinical out-
come.
18 Other conflicting results have also been reported.
19,20 
These differences likely reflect the heterogeneity of presenta-
tion of SZ, the likely impact of sample size variation and 
even subtle diagnostic differences.
21
Under the assumption that the sex differences reflect the 
impact of factors that are inherent to the disorder, many in-
vestigators have explored biological factors. Some studies have 
revealed differences in imaging variables
22,23 as well as chro-
mosome related differences.
24 The most extensive focus has 
been on hormonal differences, possibly related to dopamine 
dysfunction.
14,25-28 
It has been suggested that the later onset among women 
may be related to a protective effect of estrogens.
28 Convinc-
ing biological explanations for sex related clinical differenc-
es have not been obtained, possibly because such explana-
tions do not take into account diverse influences, including 
social variables.
4,29-31
Almost all these data originate from Caucasian samples, but 
there is some evidence for ethnic variation with regard to these 
differences. For example, the well established sex difference 
in age at onset has not been detected in four studies from the 
Indian sub-continent.
32-35 Another group found that Asian pa-
tients had lower prevalence of TD than North American, Eu-
ropean, and African patients.
7 Thus, cross-ethnic studies may 
provide additional insights into the sex differences in SZ. 
We have analyzed differences among men and women in re-
lation to clinical variation in two large independent samples, 
one recruited from north eastern USA and another from nor-
thern India. Both samples were recruited and evaluated using 
the same designs, enabling meaningful comparisons. 
Methods
Study design
We aimed to identify variables with sex based differences 
that were consistent across the Indian and US samples. To re-
duce the likelihood of false positive results, analyses were 
conducted in two stages. In view of likely cross-national dif-
ferences, we initially analyzed the samples separately using 
univariate analyses (Stage I). Only variables that remained 
significant following conservative Bonferoni corrections were 
retained for further analysis. These variables were used as de-
pendent variables in multivariate analyses that included site 
as well as key demographic and clinical variables as covari-
ates (Stage II).
Variables used for analysis
Patients with SZ or schizoaffective disorder were recruited 
from treatment facilities in US and India as described.
36,37 The 
primary recruitment sites were Dr. Ram Manohar Lohia Hos-
pital (RML), a publicly funded tertiary care center providing 
inpatient and outpatient care New Delhi, India and Universi-
ty of Pittsburgh, USA. Participants were sought among inpa-
tients and outpatients at publicly funded hospitals and private 
clinics in both cities, so as to sample from the spectrum of 
care available at each site. Recruiters approached various psy-
chiatrists in different private and public hospitals and request-
ed the psychiatrists to refer willing persons with SZ or schi-
zoaffective patients for the participation. The consented in-
dividuals were referred to us and after documenting informed 
consent, they were enrolled in to the study. 
Briefly, potentially eligible patients diagnosed clinically 
with SZ or psychoses were interviewed using the English or 
the Hindi versions of the Diagnostic Interview for Genetic 
Studies (DIGS), a semi-structured interview schedule.
38,39 
The reliability of the English and the Hindi versions of the 
DIGS have been investigated.
38,39 The DIGS includes sections 
covering different domains of psychopathology. Each section 
typically begins with screening questions that enable partici-
pants to ‘skip out’ if initial responses are negative. The fol-
lowing sections of the DIGS were completed routinely: De-
mographic details, Medical history, Overview of psychiatric 
illness, Major Depression, Mania/Hypomania, Dysthymia, Al-
cohol abuse and dependence, Drug abuse and dependence, 
Psychosis, Comorbidity assessment, Suicidal Behaviour. On-
set age of psychosis was assessed in a standardized manner 
as described in question 64 of psychosis section of the DIGS, 
in India as well as in US. Additional scales that form part of 
the DIGS were also administered, namely the Global Assess-
ment Scale,
40 the Scale for Assessment of Negative symp-
toms,
41 the Scale for Assessment of Positive Symptoms,
42 Schi-
zotypy Interview Schedule (SIS) 
43 and the OPCRIT.
44 Infor-
mation was also obtained from medical records, as well as 
from relatives and relevant clinicians. The information was 
synthesized and presented to board certified psychiatrists for 
consensus diagnosis. Inter-rater and inter-site diagnostic reli-
ability was monitored throughout the study. All participants 
provided written informed consent, as required by the Uni-
versity of Pittsburgh Institutional Review Board and the Eth-
ics Committee at Dr Ram Manohar Lohia Hospital, New 
Delhi. 
Statistical analysis
Variables were compared using the chi-square test or the 
Student’s t-test as appropriate. The Bonferroni correction was 
used to account for multiple comparisons. We further anal-
ysed such statistically significant variables, using logistic re-
gression and multinomial regression. The Statistical Package P Thomas et al. 
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for the Social Sciences versions 14 and 16 (SPSS 14, 16) were 
used for all analyses.
Results
Stage I: Univariate analyses
In view of ‘skip outs’ in different parts of the DIGS, the 
number of participants who responded to individual questions 
varied. A total of 635 records each with 240 variables from 
USA and 891 records with 230 variables from India were in-
cluded for analysis.
The demographic variables and DSM-IV diagnoses for the 
participants are provided in Table 1. There were 395 men in 
the US sample (62.2%) and 488 men in the Indian sample 
(54.8%). The mean age of the US participants was 38.6 years 
[standard deviation (SD)=9.7] and that of Indian participants 
was 30.7 (SD=9.6). The mean age at onset for the US partici-
pants was 20.2 years (SD=7.1) and that of Indian participants 
was 22.8 (SD=7.1). In the US sample, 46.3% of the men and 
50% of the women had more than 12 years of education. In 
the Indian sample, 36.9% of the men and 39.1% of the wom-
en had more than 12 years of education.
Sex based analyses
Age, onset age and education were not significantly differ-
ent by sex in the US or the Indian sample. Additional compar-
isons by sex were then conducted.
US sample
Among the US patients, significant male-female differenc-
es exceeded chance predictions (15/240 variables at p=0.02 
or better, 6.25%; detailed list in Supplementary Table 1). 
Following Bonferroni corrections for multiple comparisons, 
eight variables were significantly different (Table 2, Supple-
mentary Table 1). SZ was the more frequent diagnosis among 
men (66.6%). Among women, SZ and schizoaffective disor-
der were diagnosed more evenly (50.8% vs. 49.2%). The ma-
jority of male patients did not have children (77.8%), while 
proportionately more women (47.5%) had one or more chil-
dren. A higher proportion of men (18.2%) had joined the 
military (71 participants). Cannabis abuse was more common 
among men (73.6%) than women (58.2%). Men were more like-
Table 1. Demographic and clinical characteristics of the samples
US (N=635) India (N=891)
Male
(N=395, 62.2%)
Female
(N=240, 37.8%)
Male
(N=488, 54.8%)
Female
(N=403, 45.2%)
Age (years) 38.05 (9.7) 39.59 (9.7) 31.11 (9.6) 30.11 (9.59)
Education (years)
    0-10  .0063 (16) .0039 (16.2) .0200 (41) .0159 (39.6)
    10-12 .0148 (37.7) .0080 (33.3) .0108 (22.1) .0086 (21.4)
    >12 .0182 (46.3) .0120 (50) .0180 (36.9) .0157 (39.1)
Age at onset (years) 19.77 (6.2) 20.96 (8.4) 23.06 (6.82) 22.46 (7.38)
Numbers shown as means. The numbers in brackets indicate percentages for discontinuous variables or standard deviations for con-
tinuous variables
Table 2. US sample: variables with significant gender differences following corrections for multiple comparisons
Demographics Male, N (%) Female, N (%) p-value*, d.f., Chi-value
Diagnosis 
SZ/SZA 263 (66.6)/132 (33.4)  122 (50.8)/118 (49.2) 0.01968, 1, 15.513 
Current marital status (ever/never) 081 (20.6)/313 (79.2) 103 (43.3)/135 (56.7) 0.00024, 1, 37.108
Number of living children (0/1/>1) 298 (77.8)/40 (10.4)/45 (11.7) 126 (52.5)/35 (14.6)/79 (32.9) 0.01224, 2, 19.756
Ever been in military (yes/no) 071 (18.2)/320 (81.8) 010 (4.2)/229 (95.8) 0.00024, 1, 25.854
Drug abuse
Ever used marijuana (yes/no) 285 (73.6)/102 (26.4) 138 (58.2)/99 (41.8) 0.01512, 1,15.997
Ever used hallucinogens to feel good
  or high (yes/no)
125 (35.6)/226 (64.4) 039 (18.2)/175 (81.8) 0.00024, 1, 19.512
Medical history
Thyroid/Hormonal disorders (yes/no) 035 (9)/352 (91) 058 (24.8)/176 (75.2) 0.00024, 1, 28.382
Migraine/Headaches (yes/no) 058 (15.3)/321 (84.7) 080 (34.6)/151 (65.4) 0.00024, 1, 30.63
*p-values corrected for multiple comparisons. SZ: schizophrenia, SZA: schizoaffective disorder12  Psychiatry Investig 2010;7:9-16
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ly to be unmarried (79.2% vs. 56.7%). Women were more 
likely to report the presence of thyroid or other hormonal dis-
orders (male : female; 9% : 24.8%) or migraine headaches 
(male : female; 15.3% : 34.6%).
Indian sample
Four variables were significantly different following Bon-
ferroni corrections (Table 3, Supplementary Table 2). Drug or 
alcohol consumption was more common among men than wo-
men. Women were more frequent in the category of ‘showing 
emotions that did not fit for what was going on’ (men : wom-
en; 42.2% : 54.9%). Compared to women, more men were 
categorized as having continuous chronic illness with deteri-
oration (Opcrit rating scale, Q1).
Stage II: Post-hoc multivariate analyses
After completing the univariate analyses, we conducted post-
hoc multivariate analyses to further explore the observed dif-
ferences, in the presence of significant covariates. Only Bon-
feroni corrected significant variables from the Indian or the US 
samples were included as outcome variables (Table 1-3). In the 
combined US and Indian samples, age, age at onset and educa-
tion were included as covariates, with sex and nationality as the 
independent variables. We included age at onset as an index of 
illness severity. The following variables were not included for 
post-hoc analyses due to lack of sufficient sample cell sizes in 
one or both samples: thyroid diseases, ‘ever been in military’, 
‘ever used marijuana’, ‘ever used hallucinogen to feel good or 
high’, ‘ever consumed alcohol regularly’.
Sex continued to be a significant predictor for four vari-
ables: course of the disorder [p=0.00023; OR 0.66, 95% con-
fidence interval (CI) 1.808, 1.984]; life time history of ‘show-
ing emotions that did not fit for what was going on’ (p= 
0.00047; OR 0.638, 95% CI 0.496, 0.821), marital status (p= 
0.0011; OR 0.662, 95% CI 1.225, 2.255), number of living 
children (p=0.000001; OR 0.472, 95% CI 0.368, 0.606).
Discussion
Several variables with sex related differences were noted 
in the US and the Indian samples, but four were noted across 
both samples through multivariate analyses. They include the 
course of the illness, history of inappropriate emotions, mari-
tal status and number of children. The consistency across 
very diverse settings noted for these variables likely under-
scores their importance in the presentation of SZ. Others have 
reported cross-national or ethnic variation in the course of the 
disorder,
8,17 but the differences with regard to inappropriate 
emotions are novel, to our knowledge. We have previously 
reported on sex based differences in marital status and num-
ber of children in the USA, as well as India.
32 The samples 
analyzed in the present study overlap with the published data, 
so the present results should not be considered to be replica-
tions of our earlier report. Nevertheless, the consistency in 
sex based procreational indices reflects an important aspect 
of the disorder. The lack of overlap between the US and In-
dian samples for several other variables requires further in-
vestigation. Multivariate analyses revealed sex by nationality 
interactions for several of these variables (data not shown). It 
is possible that they are impacted by cultural, environmental 
or genetic differences across the sites. 
Many of the sex based differences noted in the US sample 
are consistent with earlier reports. Two thirds of the US male 
participants were diagnosed with SZ, the remaining men be-
ing diagnosed with schizoaffective disorder. Men were more 
likely to be unmarried, to have fewer children than women 
and to have served in the military. They had more hospitaliza-
tions than women. In developed countries, sex has previously 
been reported to be significantly associated with diagnosis
2,21; 
marital status
2,11,13,18,19,32 and number of living children.
32 Men 
are reported to have more hospitalizations and longer hospi-
tal stays than women.
10,11,45 Premenopausal women appear to 
experience an overall better course of the illness compared to 
Table 3. Indian sample: variables with significant gender differences following corrections for multiple comparisons
Male, N (%) Female, N (%) p-value, d.f., Chi-value
Drug abuse: ever used marijuana
    Ever/Never 28 (5.9)/445 (94.1) 2 (0.5)/386 (99.5)  0.00024, 1, 18.51
Alcohol abuse: ever drink alcohol
    Ever/Never 133 (27.5)/350 (72.5) 5 (1.3)/380 (98.7) 0.00024, 1, 110.29
Psychosis: ever show emotions that did not fit what
  was going on (Q58 from psychosis section, DIGS)
    Yes/ No 206 (42.2)/282 (57.8) 219 (54.9)/180 (45.1) 0.048, 1, 14.13
Opcrit
    Q1. Course disorder 1/2/3/4/5 29/39/63/37/308 32/65/60/15/223 0.042, 4, 22.3
Only variables that would remain significant following Bonferroni corrections are listed. *p-values corrected for multiple comparisons. 
1: single episode with good recovery, 2: multiple episodes with good recovery between episodes, 3: multiple episodes with partial re-
covery between episodes, 4: continuous chronic illness without/deterioration, 5: continuous chronic illness with deterioration. DIGS: 
Diagnostic Interview for Genetic StudiesP Thomas et al. 
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men.
26 The sex based differences noted in our sample are 
thus consistent with several prior reports.
3,4,11,26,31,45-48 These 
differences are postulated to be due to biological differences, 
including hormonal changes.
4,28,31 Others have suggested pro-
teins encoded by sex chromosomes [Monoamine oxidase 
(MAO) or candidates gene variants
24 as causal]. 
Our Indian sample was ascertained and evaluated in the 
same manner as our US sample. It was substantially larger 
than the US sample. However, fewer variables differed signifi-
cantly in the Indian sample following correction for multiple 
comparisons. Some variables showed sex related differences 
in both samples, though they did not remain significant fol-
lowing Bonferoni corrections (Table 2, 3; supplementary Ta-
ble 1, 2). For example, migraine, as well as thyroid disorders 
was reported more often by women in the US sample. Thy-
roid disorders were also more commonly reported by Indian 
women, but migraine was not associated with gender in In-
dia. Thyroid disorders and migraine are more frequent among 
women in population based surveys,
49-51 so the sex differenc-
es observed here may not be related to SZ per se. Grandiose 
delusions were more common among men in both samples. 
Chu and colleagues
52 reported that men with SZ were slower, 
hypoactive, and grandiose, while Galdos
53 did not report such 
associations in a UK sample.
More men than women were likely to have used alcohol at 
least once in the Indian sample, consistent with Indian cultur-
al traditions. A similar difference in lifetime alcohol use was 
not observed in the US sample, though US male patients were 
more likely to have used alcohol for at least 6 months on a 
regular basis. In both the samples, women were more likely to 
rate positive for the variable, ‘returned to normal self at least 
two months’ (Q66, Psychosis section of DIGS). This is consis-
tent with some earlier reports- Salem and Kring
31 document-
ed that men had poorer course and medication response, poor-
er premorbid social and intellectual functioning.
Some limitations of the present study need to be considered. 
Though we aimed for representative samples, neither the US 
nor the Indian samples were ascertained randomly. Thus, nei-
ther sample can be considered representative of patients in 
the US or India. As there were no exclusions based on gen-
der, however, the gender related differences noted here are 
unlikely to reflect selection bias. Medications very likely im-
pact on many of the variables listed here, and men are known 
to receive higher doses of medications than women.
31 As ac-
curate medication data were not available, we included age 
at onset in our multivariate analyses. As this variable is cor-
related with illness severity, we reasoned that it could func-
tion as a crude index of illness severity. In addition, we ana-
lyzed psychopathology in relation to lifetime occurrence. 
Conclusion
Four variables appear to be consistently observed across 
both samples, after accounting for key clinical and demo-
graphic variables. Different patterns of sex related differenc-
es were observed among US and Indian patients with regard 
to other variables, suggesting an impact of environmental/cul-
tural factors. 
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Supplementary Table 1. US sample: Nominally significant sex based differences
Demographics N
Sex (M, F)
frequency
Chi-value/
t-value
d.f p-value
Diagnosis SZ/SZA 635 263/132, 122/118  15.513 1 0.000082
Current marital status (Ever/never) 632 81/313, 103/135 37.108 1 0.000001
Number of children (0/1/>1) 623 298/40/45, 126/35/79 19.576 2 0.000051
Ever been in military 630 71/320, 10/229 25.854 1 0.000001
Drugs
Ever Used marijuana  624 285/102, 138/99 15.997 1 0.000063
Ever used Hallucinogens to feel good or high or 
  to feel active or alert
565 125/226, 39/175 19.512 1 0.000010
Alcohol
Ever drink alcohol regularly at least once a week 
  for six months or more (Q5, Alcohol)
578 156/206, 117/101 07.935 1 0.004850
Ever get drunk that is, when your speech was slurred or 
  you were unsteady on your feet
567 82/275, 64/148 04.493 1 0.034000
Medical history
Number of overnight hospital stay including surgery 550 - 13.252 3 0.004121
Thyroid or other hormonal disorders 621 35/352, 58/176 28.382 1 0.000001
Migraine/Head aches 610 58/321, 80/151 30.630 1 0.000001
Vitamin deficiency 615 365/16, 211/25 09.796 1 0.001749
Major depression
Ever had a period at least one week bothered most of the day
  feeling depressed sad down low q1
612 120/244, 48/175 13.509 1 0.000237
Ever had a period at least one week not enjoy most things 
  usually like to do Q2
587 122/258, 46/186 11.244 1 0.000799
If any symptoms like, loss of appetite, sleeping problems, 
  talking problems, thinking disability or guilty feeling 
  were present q6
426 73/173, 28/152 11.456 1 0.000713
Seek or receive help from a doctor or other professional q23 422 49/193, 19/161 09.170 1 0.002460
Only variables that remained significant at p=0.02 or better are shown (p-values uncorrected for multiple comparisons)16  Psychiatry Investig 2010;7:9-16
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Supplementary Table 2. India sample: Nominally significant sex based differences
Demographics N
Sex (Male, Female)
frequency
Chi-value/
t-value
d.f p-value
Medical history
Thyroid/Hormonal problems 803 434/1, 355/13 12.694 1 0.000456*
Smoked cigarettes daily basis 785 260/166, 353/6 158.38 1 0.000001*
Drugs, Alcohol
Ever used marijuana (ever/never) 861 28/445, 2/386 18.511 1 0.000001*
Ever used alcohol (Q1, alcohol) (ever/never) 868 133/350, 5/380 110.299 1 0.000001*
OPCRIT
Course disorder (1/2/3/4/5)† 871 29/39/63/37/308, 
32/65/60/15/223
22.295 4 0.000175*
Psychosis
Ever returned to normal self for at least two months 864 334/141, 236/153 8.867 1 0.003106*
Grandiose delusions 858 323/145, 308/82 10.840 1 0.001083*
Being controlled 858 300/168, 281/109 6.148 1 0.015468†
Thought broadcasting 858 403/66, 355/34 5.871 1 0.018419†
Ever show emotions that did not fit what was going on  887 206/ 282, 219/180 14.129 1 0.000200*
Return to feeling like your normal self for 
  at least two months
890 343/145, 246/156
 
8.142 1 0.004462*
Number of episodes (Q67 Psychosis) 881 - -2.575 0.006565*
Longitudinal course 888 78/39/327/27/15, 
71/61/236/19/15
13.440 4 0.009301*
Only variables that remained significant at p=0.02 or better are shown (*p-values uncorrected for multiple comparisons). †1: Single 
episode with good recovery, 2: Multiple episodes with good recovery between episodes, 3: Multiple episodes with partial recovery 
between episodes, 4: Continuous chronic illness without/deterioration, 5: Continuous chronic illness with deterioration